Related references
Note: Only part of the references are listed.Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome
Jessica K. Devin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Weight Loss Improves β-Cell Function in People With Severe Obesity and Impaired Fasting Glucose: A Window of Opportunity
Amy E. Rothberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitors
Carolyn F. Deacon
PEPTIDES (2020)
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Steven P. Marso et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon- like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes
Michael A. Nauck et al.
DIABETES OBESITY & METABOLISM (2017)
A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients
Mirna S. Abd El Aziz et al.
DIABETES OBESITY & METABOLISM (2017)
A Multicenter Observational Study of Incretin-based Drugs and Heart Failure
Kristian B. Filion et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes
Zuzana Kovacova et al.
OBESITY (2016)
Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein versus high carbohydrate diet: randomized control trial
Frankie B. Stentz et al.
BMJ OPEN DIABETES RESEARCH & CARE (2016)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Francisco Kerr Saraiva et al.
CARDIOVASCULAR DIABETOLOGY (2014)
MECHANISMS IN ENDOCRINOLOGY Regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
Kristy M. Heppner et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic β-cell impairments in type 2 diabetes
Stephane Dalle et al.
CELLULAR SIGNALLING (2013)
The Place of GLP-1-Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
Dara L. Eckerle Mize et al.
CURRENT DIABETES REPORTS (2013)
Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus
D. R. Owens et al.
DIABETES & METABOLISM (2013)
Effects of High-Protein Versus High-Carbohydrate Diets on Markers of β-Cell Function, Oxidative Stress, Lipid Peroxidation, Proinflammatory Cytokines, and Adipokines in Obese, Premenopausal Women Without Diabetes A randomized controlled trial
Abbas E. Kitabchi et al.
DIABETES CARE (2013)
The Cardiovascular Effects of GLP-1 Receptor Agonists
Theodore Okerson et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
Vanita R. Aroda et al.
CLINICAL THERAPEUTICS (2012)
Insulin Sensitivity, β-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels
Maria A. Marini et al.
DIABETES CARE (2012)
Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating A Randomized Controlled Trial
George A. Bray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2011)
Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation
Kailash N. Pandey
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2011)
DPP-4 Inhibitors Impact on glycemic control and cardiovascular risk factors
Dror Dicker
DIABETES CARE (2011)
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors Similarities and Differences
Roberta Baetta et al.
DRUGS (2011)
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
Giuseppe Derosa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
Jonatan I. Bagger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Improved Pancreatic β-Cell Function in Type 2 Diabetic Patients After Lifestyle-Induced Weight Loss Is Related to Glucose-Dependent Insulinotropic Polypeptide
Thomas P. J. Solomon et al.
DIABETES CARE (2010)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
Wook Kim et al.
PHARMACOLOGICAL REVIEWS (2008)
Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals
Thomas J. Wang et al.
CIRCULATION (2007)
Ghrelin:: a hormone regulating food intake and energy homeostasis
Mercedes Gil-Campos et al.
BRITISH JOURNAL OF NUTRITION (2006)
Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes
JF Gautier et al.
DIABETES & METABOLISM (2005)
N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: Comparison with patients in different stages of heart failure
KM Hermann-Arnhof et al.
CLINICAL CHEMISTRY (2005)
Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure
Y Seino et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Impact of obesity on plasma natriuretic peptide levels
TJ Wang et al.
CIRCULATION (2004)
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises
FB Stentz et al.
DIABETES (2004)
β-cell function in obesity -: Effects of weight loss
E Ferrannini et al.
DIABETES (2004)
GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
B Ahrén et al.
HORMONE AND METABOLIC RESEARCH (2004)
A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women
DK Layman et al.
JOURNAL OF NUTRITION (2003)
High-protein weight-loss diets: Are they safe and do they work? A review of the experimental and epidemiologic data
J Eisenstein et al.
NUTRITION REVIEWS (2002)
The glycemic index - Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease
DS Ludwig
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
DE Cummings et al.
DIABETES (2001)
Determinants of glucose toxicity and its reversibility in the pancreatic islet β-cell line, HIT-T15
CE Gleason et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2000)
Share Paper
